Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide PET Radiopharmaceuticals market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 4.7% during the forecast period.
This report presents the market size and development trends by detailing the PET Radiopharmaceuticals market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the PET Radiopharmaceuticals market will be shown in this report. In short, this report will comprehensively reveal the characteristics of PET Radiopharmaceuticals industry and will help you to build a panoramic view of the industrial development.
PET Radiopharmaceuticals Market, By Type:
F-18
Ru-82
Others
PET Radiopharmaceuticals Market, By Application:
Oncology
Cardiology
Neurology
Others
Some of the leading players are as follows:
Nordion, Inc (Canada)
Mallinckrodt plc (Ireland)
Lantheus Medical Imaging, Inc. (U.S.)
GE Healthcare (U.K.)
Advanced Accelerator Applications SA (France)
Cardinal Health Inc. (U.S.)
Nordion, Inc. (Canada)
Advanced Accelerator Applications S.A. (France)
Cardinal Health Inc (US)
Bracco Imaging S.p.A (Italy)
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 PET Radiopharmaceuticals Market: Technology Type Analysis
-
4.1 PET Radiopharmaceuticals Technology Type Market Share Analysis, 2018 & 2026
-
4.2 PET Radiopharmaceuticals Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 F-18
4.3.2 Ru-82
4.3.3 Others
5 PET Radiopharmaceuticals Market: Product Analysis
-
5.1 PET Radiopharmaceuticals Product Market Share Analysis, 2018 & 2026
-
5.2 PET Radiopharmaceuticals Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 PET Radiopharmaceuticals Market: Application Analysis
-
6.1 PET Radiopharmaceuticals Application Market Share Analysis, 2018 & 2026
-
6.2 PET Radiopharmaceuticals Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Oncology
6.3.2 Cardiology
6.3.3 Neurology
6.3.4 Others
7 PET Radiopharmaceuticals Market: Regional Analysis
-
7.1 PET Radiopharmaceuticals Regional Market Share Analysis, 2018 & 2026
-
7.2 PET Radiopharmaceuticals Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 Nordion, Inc (Canada)
9.1.1 Nordion, Inc (Canada) Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 Mallinckrodt plc (Ireland)
9.2.1 Mallinckrodt plc (Ireland) Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 Lantheus Medical Imaging, Inc. (U.S.)
9.3.1 Lantheus Medical Imaging, Inc. (U.S.) Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 GE Healthcare (U.K.)
9.4.1 GE Healthcare (U.K.) Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 Advanced Accelerator Applications SA (France)
9.5.1 Advanced Accelerator Applications SA (France) Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 Cardinal Health Inc. (U.S.)
9.6.1 Cardinal Health Inc. (U.S.) Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 Nordion, Inc. (Canada)
9.7.1 Nordion, Inc. (Canada) Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 Advanced Accelerator Applications S.A. (France)
9.8.1 Advanced Accelerator Applications S.A. (France) Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 Cardinal Health Inc (US)
9.9.1 Cardinal Health Inc (US) Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
9.10 Bracco Imaging S.p.A (Italy)
9.10.1 Bracco Imaging S.p.A (Italy) Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis
The List of Tables and Figures (Totals 69 Figures and 127 Tables)
Figure F-18 PET Radiopharmaceuticals market, 2015 - 2026 (USD Million)
Figure Ru-82 PET Radiopharmaceuticals market, 2015 - 2026 (USD Million)
Figure Others PET Radiopharmaceuticals market, 2015 - 2026 (USD Million)
Figure Oncology market, 2015 - 2026 (USD Million)
Figure Cardiology market, 2015 - 2026 (USD Million)
Figure Neurology market, 2015 - 2026 (USD Million)
Figure Others market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America PET Radiopharmaceuticals market, by country, 2015 - 2026 (USD Million)
-
Table North America PET Radiopharmaceuticals market, by type, 2015 - 2026 (USD Million)
-
Table North America PET Radiopharmaceuticals market, by product, 2015 - 2026 (USD Million)
-
Table North America PET Radiopharmaceuticals market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. PET Radiopharmaceuticals market, by type, 2015 - 2026 (USD Million)
-
Table U.S. PET Radiopharmaceuticals market, by product, 2015 - 2026 (USD Million)
-
Table U.S. PET Radiopharmaceuticals market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada PET Radiopharmaceuticals market, by type, 2015 - 2026 (USD Million)
-
Table Canada PET Radiopharmaceuticals market, by product, 2015 - 2026 (USD Million)
-
Table Canada PET Radiopharmaceuticals market, by application, 2015 - 2026 (USD Million)
-
Table Europe PET Radiopharmaceuticals market, by country, 2015 - 2026 (USD Million)
-
Table Europe PET Radiopharmaceuticals market, by type, 2015 - 2026 (USD Million)
-
Table Europe PET Radiopharmaceuticals market, by product, 2015 - 2026 (USD Million)
-
Table Europe PET Radiopharmaceuticals market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. PET Radiopharmaceuticals market, by type, 2015 - 2026 (USD Million)
-
Table U.K. PET Radiopharmaceuticals market, by product, 2015 - 2026 (USD Million)
-
Table U.K. PET Radiopharmaceuticals market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany PET Radiopharmaceuticals market, by type, 2015 - 2026 (USD Million)
-
Table Germany PET Radiopharmaceuticals market, by product, 2015 - 2026 (USD Million)
-
Table Germany PET Radiopharmaceuticals market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France PET Radiopharmaceuticals market, by type, 2015 - 2026 (USD Million)
-
Table France PET Radiopharmaceuticals market, by product, 2015 - 2026 (USD Million)
-
Table France PET Radiopharmaceuticals market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy PET Radiopharmaceuticals market, by type, 2015 - 2026 (USD Million)
-
Table Italy PET Radiopharmaceuticals market, by product, 2015 - 2026 (USD Million)
-
Table Italy PET Radiopharmaceuticals market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain PET Radiopharmaceuticals market, by type, 2015 - 2026 (USD Million)
-
Table Spain PET Radiopharmaceuticals market, by product, 2015 - 2026 (USD Million)
-
Table Spain PET Radiopharmaceuticals market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific PET Radiopharmaceuticals market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific PET Radiopharmaceuticals market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific PET Radiopharmaceuticals market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific PET Radiopharmaceuticals market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China PET Radiopharmaceuticals market, by type, 2015 - 2026 (USD Million)
-
Table China PET Radiopharmaceuticals market, by product, 2015 - 2026 (USD Million)
-
Table China PET Radiopharmaceuticals market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan PET Radiopharmaceuticals market, by type, 2015 - 2026 (USD Million)
-
Table Japan PET Radiopharmaceuticals market, by product, 2015 - 2026 (USD Million)
-
Table Japan PET Radiopharmaceuticals market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India PET Radiopharmaceuticals market, by type, 2015 - 2026 (USD Million)
-
Table India PET Radiopharmaceuticals market, by product, 2015 - 2026 (USD Million)
-
Table India PET Radiopharmaceuticals market, by application, 2015 - 2026 (USD Million)
-
Table Latin America PET Radiopharmaceuticals market, by country, 2015 - 2026 (USD Million)
-
Table Latin America PET Radiopharmaceuticals market, by type, 2015 - 2026 (USD Million)
-
Table Latin America PET Radiopharmaceuticals market, by product, 2015 - 2026 (USD Million)
-
Table Latin America PET Radiopharmaceuticals market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil PET Radiopharmaceuticals market, by type, 2015 - 2026 (USD Million)
-
Table Brazil PET Radiopharmaceuticals market, by product, 2015 - 2026 (USD Million)
-
Table Brazil PET Radiopharmaceuticals market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico PET Radiopharmaceuticals market, by type, 2015 - 2026 (USD Million)
-
Table Mexico PET Radiopharmaceuticals market, by product, 2015 - 2026 (USD Million)
-
Table Mexico PET Radiopharmaceuticals market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina PET Radiopharmaceuticals market, by type, 2015 - 2026 (USD Million)
-
Table Argentina PET Radiopharmaceuticals market, by product, 2015 - 2026 (USD Million)
-
Table Argentina PET Radiopharmaceuticals market, by application, 2015 - 2026 (USD Million)
-
Table MEA PET Radiopharmaceuticals market, by country, 2015 - 2026 (USD Million)
-
Table MEA PET Radiopharmaceuticals market, by type, 2015 - 2026 (USD Million)
-
Table MEA PET Radiopharmaceuticals market, by product, 2015 - 2026 (USD Million)
-
Table MEA PET Radiopharmaceuticals market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa PET Radiopharmaceuticals market, by type, 2015 - 2026 (USD Million)
-
Table South Africa PET Radiopharmaceuticals market, by product, 2015 - 2026 (USD Million)
-
Table South Africa PET Radiopharmaceuticals market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria PET Radiopharmaceuticals market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria PET Radiopharmaceuticals market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria PET Radiopharmaceuticals market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table Nordion, Inc (Canada) Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Mallinckrodt plc (Ireland) Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Lantheus Medical Imaging, Inc. (U.S.) Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table GE Healthcare (U.K.) Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Advanced Accelerator Applications SA (France) Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Cardinal Health Inc. (U.S.) Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Nordion, Inc. (Canada) Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Advanced Accelerator Applications S.A. (France) Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Cardinal Health Inc (US) Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Bracco Imaging S.p.A (Italy) Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
-
